Year All2024202320222021202020192018201720162015201420132012 ADMA Biologics Announces Third Quarter 2024 Financial Results and Provides Business Update Nov 07, 2024 ADMA Biologics to Report Third Quarter 2024 Financial Results on November 7, 2024 Oct 29, 2024 ADMA Biologics Set to Join S&P SmallCap 600 Index Sep 17, 2024 ADMA Biologics to Participate in the 2024 Cantor Global Healthcare Conference Sep 10, 2024 ADMA Biologics Announces Partial Paydown of Revolving Credit Facility Aug 14, 2024 ADMA Biologics Announces Second Quarter 2024 Financial Results and Provides Business Update Aug 08, 2024 ADMA Biologics to Report Second Quarter 2024 Financial Results on August 8, 2024 Aug 01, 2024 ADMA Biologics Announces First Quarter 2024 Financial Results and Provides Business Update May 09, 2024 ADMA Biologics to Report First Quarter 2024 Financial Results on May 9, 2024 May 02, 2024 ADMA Biologics Announces FDA Approvals of Extended Room Temperature Storage Conditions for ASCENIV™ & BIVIGAM® Mar 11, 2024
ADMA Biologics Announces Third Quarter 2024 Financial Results and Provides Business Update Nov 07, 2024
ADMA Biologics Announces Second Quarter 2024 Financial Results and Provides Business Update Aug 08, 2024
ADMA Biologics Announces First Quarter 2024 Financial Results and Provides Business Update May 09, 2024
ADMA Biologics Announces FDA Approvals of Extended Room Temperature Storage Conditions for ASCENIV™ & BIVIGAM® Mar 11, 2024
